New test will analyze DNA to predict risk of prostate cancer

01/16/2008 | NYTimes.com

A team of U.S. scientists found that men with a combination of common and minor variations in five DNA regions are more likely to develop prostate cancer than those who had none of the variants. ProActive Genetics is expected to develop a test that could help providers predict a man's risk of getting the disease via DNA analysis of saliva or blood samples.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA